Pharmafile Logo
Pharmafocus logo
Advanced Search
brexit_flag_0

Ministers move to clarify drug regulation Post-Brexit

July 4, 2017
Manufacturing and Production, Medical Communications EMA, Jeremy Hunt, MHRA, NHS, NICE

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

News
astrazeneca_building_white

AstraZeneca generates $600 million from just two drug sales

July 3, 2017
Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig

AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …

News

Forging a path forward in neurological disorders

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …

Feature
index_ph001

Big success and even bigger failure for Daiichi Sankyo’s experimental therapy

July 3, 2017
Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin

Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …

News
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017
Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …

News
astrazeneca_sign_sky

New Pfizer EU approval offers first treatment option for leukaemia subtype

July 3, 2017
Sales and Marketing AstraZeneca, Besponsa, EU, European Commission

Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …

News
veeva_webinar

Free Webinar: How will quality management change by 2025?

July 3, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Webinar, veeva

Following on from the success of our previous free webinar sessions, Pharmafocus is partnering

News

NICE recommends AstraZeneca lung treatment

July 3, 2017
Sales and Marketing AstraZeneca, Daxas, NICE

AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …

News

Pricing Consultant Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Pricing Consultant Job Profile and Description About Global Pricing Innovations (GPI)

Appointment

Head of Product Innovation Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Head of Product Innovation Job Profile and Description About Global Pricing Innovations (GPI)

Appointment

Development Manager Job Profile and Description

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI

Development Manager Job Profile and DescriptionGPI is a global pricing consultancy launching products, services and offerings that make a measurable …

Appointment

ABPI reveals 10% increase in HCP payment disclosure

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, disclosure, disclosure uk

The headline news from the ABPI’s press conference on Disclosure UK was that healthcare professionals’ (HCPs) disclosure of payments for …

News

Eli Lilly arthritis drug outperforms Humira and receives NICE backing

June 30, 2017
Medical Communications, Research and Development, Sales and Marketing Eli Lilly, NICE, Olumiant, rheumatoid arthritis

Eli Lilly’s rheumatoid arthritis (RA) drug Olumiant (baricitinib) has been deemed cost-effective by NICE and has been recommended to be …

News
shutterstock_212432119

The pharmaceutical research and development challenge

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Mylan …

News
martin_shkreli_2016

‘He was born this way’, Shkreli case becomes circus

June 29, 2017
Medical Communications Martin Shkreli, Shkreli, Turing Pharmaceutical, turing

Martin Shkreli’s Attorney, Benjamin Brafman, defended his client in a bizarre reference to a pop singer, “As Lady Gaga would …

News
shutterstock_273326141

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

June 29, 2017
Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …

News
ingram_headshot

Sarepta appoints ex-Allergan President as new CEO

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sarepta Therapeutics

Sarepta Therapeutics has announced the appointment of ex-Allergan President Doug Ingram as the company’s new CEO – it’s third in …

Appointment
pounds_stacked

Regulators get aggressive on matters excessive

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …

Feature
heather_bresch_2

Investors demand resignation of Mylan executives over pay packages

June 29, 2017
Sales and Marketing Heather Bresch, Mylan, epipen

As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026